Opioid-related Adverse Drug Reactions in Patients Visiting the Emergency Division of a Tertiary Hospital
Overview
Authors
Affiliations
Opioid use and associated morbidity and mortality have increased in several countries during the past 20 years. We performed a study whose objective was to assess the frequency and causes of opioid-related emergency division (ED) visits in an adult tertiary Swiss University Hospital over 9 weeks in 2018. We primarily assessed opioid-related adverse drug reactions (ADR), secondary overdose, misuse, abuse, and insufficient pain relief. Current opioid use was identified in 1037 (8.3%) of the 12 470 included ED visits. In 64 opioid users, an ADR was identified as a contributing cause of the ED visit, representing 6.2% of opioid users, and 0.5% of the total ED visits. Moreover, we identified an overdose in 16 opioid users, misuse or abuse in 19 opioid users, and compatible withdrawal symptoms in 7 opioid users. After pooling all these events, we conclude that the ED visits could be related to opioid use in 10.2% of opioid users. Finally, in 201 opioid users, insufficient pain relief (pain not responding to the current pharmacological treatment) was identified as a contributing cause of ED visits. In these cases, other factors than simply pharmacological nonresponse may have been involved. In the context of an ever-increasing opioid use to better control chronic pain situations, these results should reinforce emergency network epidemiological surveillance studies at a national level.
Microglia in morphine tolerance: cellular and molecular mechanisms and therapeutic potential.
Zhang X, Jin T, Wang H, Han S, Liang Y Front Pharmacol. 2024; 15:1499799.
PMID: 39669194 PMC: 11635611. DOI: 10.3389/fphar.2024.1499799.
Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.
Gustafsson M, Silva V, Valeiro C, Joaquim J, van Hunsel F, Matos C Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204114 PMC: 11357286. DOI: 10.3390/ph17081009.
Zhao Y, Mu H, Zhang J, Lu Y Exp Ther Med. 2023; 26(4):475.
PMID: 37664672 PMC: 10469147. DOI: 10.3892/etm.2023.12174.
Ing Lorenzini K, Wainstein L, Spechbach H, Sarasin F, Ramlawi M, Desmeules J Pharmacol Res Perspect. 2022; 10(6):e01033.
PMID: 36404650 PMC: 9676686. DOI: 10.1002/prp2.1033.